Evercore ISI upgrades Macerich stock rating on balance sheet gains

Evercore ISI upgraded Macerich to Outperform from In Line while maintaining a $26 price target, implying roughly 15% upside from $22.63. The upgrade cites an improving balance sheet and accelerating 2027-28 FFO growth, while Macerich targets at least 3% NOI growth in 2026 after reporting 3.8% Q2 NOI growth. Piper Sandler also upgraded the REIT to Overweight and lifted its target to $30, though elevated interest rates remain a sector headwind and InvestingPro flags MAC as overvalued versus fair value.

Analysis

MAC’s rerating case depends less on incremental same-store improvement than on whether asset-level cash flow can be translated into lower net debt and a durable reduction in refinancing risk. If management can recycle lower-growth assets or place capital into unencumbered properties without materially diluting per-share FFO, the equity could migrate from a leveraged-turnaround multiple toward the higher-quality mall cohort. The competitive implication is favorable for MAC relative to lower-productivity enclosed-mall landlords, but Simon Property Group (SPG) remains the cleaner way to own premium-mall fundamentals with materially less execution sensitivity.

The near-term upgrade cycle is likely to support momentum for days to several weeks, but the next 1-3 month catalyst must be evidence that leasing spreads, occupancy and transaction activity are improving without requiring excessive tenant incentives or capital expenditures. A rate backup is the principal risk: highly leveraged REITs typically suffer disproportionate multiple compression when long-end yields rise because the market capitalizes both higher interest expense and a lower terminal asset value. Over 6-18 months, any accretive acquisition strategy is only bullish if funded below the implied cap rate of acquired assets; otherwise, the market may view it as balance-sheet risk returning through a different channel.

Consensus may be underestimating the optionality from a successful deleveraging and quality upgrade, but it is also extrapolating a favorable operating backdrop before the financing math is fully proven. The stock’s recent strength reduces the appeal of chasing a single analyst-rating event. The thesis is falsified by a reversal in occupancy/leasing spreads, a material upward revision to interest expense, equity-funded acquisitions at a discount to NAV, or a sustained rise in the 10-year Treasury that widens MAC’s valuation discount versus SPG.

Key Decisions for Investors

• Do not chase MAC on the rating change; establish a 1-2% tactical long only on a pullback toward $21-22 or after the next earnings release confirms per-share FFO guidance and net-debt reduction. Target $26-30 over 6-12 months; exit if the stock closes below $20 following weaker guidance or a financing-related setback.
• For a market-neutral expression, long MAC / short SPG in equal dollar amounts only if MAC’s valuation discount remains wide after confirming quarterly leverage improvement. This isolates MAC’s execution rerating; review after the next two earnings reports, with a 10-15% adverse relative-performance stop.
• Use VNQ or IYR as a hedge against broad REIT duration exposure for any MAC long. If the 10-year Treasury rises roughly 40-50bp from entry without a parallel improvement in MAC’s credit metrics, reduce the position rather than treating the drawdown as company-specific.
• Monitor acquisition announcements as a decision trigger, not a catalyst by default: add only where disclosed cap rates and financing costs imply accretion to FFO per share. Equity issuance, materially higher secured borrowing, or acquisitions lacking cap-rate disclosure should trigger a downgrade to watch-only.